MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    SWALLOWING VIDEOENDOSCOPY IN PATIENTS WITH PARKINSON’S DISEASE WITH DEEP BRAIN STIMULATION

    T. Alves, N. Oliveira, G. Diaféria, M. Palumbo, MG. Ghilardi, E. Fonoff, M. Padovani (São Paulo, Brazil)

    Objective: Objective: to characterize swallowing in patients with DBS, comparing ON and OFF stimulation state. Background: Swallowing dysfunction is a frequent complication of Parkinson’s disease…
  • 2019 International Congress

    Wearable versus marker-free technologies: does it matter for clinical gait analysis?

    K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To compare wearable sensor-based and marker-less 3D video-based gait analysis in two neurodegenerative disorders associated with gait dysfunction. Background: Quantitative gait analysis supports diagnosis…
  • 2019 International Congress

    Application of the Movement Disorders Society Criteria for diagnosis of Progressive Supranuclear Palsy

    F. Ali, H. Botha, E. Ahlskog, J. Bower, A. Hassan, D. Dickson, J. Whitwell, K. Josephs (Rochester, MN, USA)

    Objective: Analyze the sensitivity, specificity of the Movement Disorders Society (MDS) criteria for progressive supranuclear palsy (PSP) and apply the multiple allocation extinction (MAX) rules…
  • 2019 International Congress

    Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson’s disease is safe and may be advantageous

    F. Baig, L. Mooney, M. Selikhova, M. Rolinski, K. Szewczyk-Krolikowski, N. Collin, A. Whone (Bristol, United Kingdom)

    Objective: We describe a case series of 12 patients requiring administration of levodopa-carbidopa intestinal gel (LCIG) who had their tube placed by  per-oral image guided…
  • 2019 International Congress

    Scene Induced emotion processing in Parkinson’s disease: BOLD-fMRI study

    S. Boujraf, M. Benzagmout, B. Alami, H. Amadou, H. El Hamdaoui, A. Bennani, M. Jaafari, I. Rammouz, M. Maaroufi, D. Boussaoud (Fez, Morocco)

    Objective: The aim of this study was to investigate emotional processing organization in the brain of patients with Parkinson's disease and to explore whether there…
  • 2019 International Congress

    PRKN Positive Parkinson’s Disease Masked as Dopa-Responsive Dystonia

    S. Chiu, A. Elkouzi, L. Almeida (Gainesville, FL, USA)

    Objective: To report a Parkinson’s disease (PD) patient with PRKN mutation initially diagnosed with dopa-responsive dystonia (DRD), unmasked after developing signs of parkinsonian disease progression.…
  • 2019 International Congress

    Parkinson’s disease and melanoma: a serie of 33 patients

    J. Doridam, M. Nader, A. Melin, MF. Avril, E. Maubec, B. Degos (Paris, France)

    Objective: The objective of our work was to characterize the clinical features of patients with malignant melanoma (MM) associated with Parkinson’s disease (PD) and to…
  • 2019 International Congress

    Study of cardiac sympathetic denervation by 18F-FDOPA PET-CT Imaging in early Parkinson disease (EPD) and Atypical parkinsonian syndromes (APS)

    K C. Chudasama, VG. Goyal, C P. Patel, MV. Srivastava, MBS. Singh, MT. Tripathi, VY. Y, AR. Roy (Delhi, India)

    Objective: To evaluate utility of l-3,4-dihydroxy-6-[18F] fluoro-phenylalanine (18F­-FDOPA) PET-CT imaging for cardiac sympathetic denervation in conjunction with nigrostriatal imaging in patients with early Parkinson disease (EPD) and Atypical…
  • 2019 International Congress

    Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson’s Disease and “OFF” Episodes: Post Hoc Analysis From a Phase 3 Study

    J. Hui, S. Fox, W. Neeson, P. Bhargava, E. Pappert, D. Blum, B. Navia (Los Angeles, CA, USA)

    Objective: To compare time to onset and magnitude of motor improvement following administration of apomorphine sublingual film (APL-130277; APL) vs levodopa in patients with Parkinson’s…
  • 2019 International Congress

    Progressive Parkinsonism and Cognitive Changes: A Rare Presentation of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)

    M. Khyat-Khoei, J. Randhawa, E. Furr-Stimming, R. Samudralwar, S. Chandra (Houston, TX, USA)

    Objective: To describe a rare manifestation of a case of CLIPPERS with video-based documentation of treatment responsiveness. Background: CLIPPERS is a rare inflammatory disease of…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley